Immunyx Pharma
Biopharmaceutical company developing novel immune modulation therapies for autoimmune diseases.
About
Immunyx Pharma is a drug development company focused on neutrophil modulation in disease. They are developing novel pharmacological approaches to safely and effectively treat deregulated neutrophil damage in large market diseases such as COPD, cancer, colitis, and arthritis.
Technology stack
detected 2026-06-14Est. monthly stack spend~$90/mo
CDN
Cloudflare
Email
Google Workspace
Stack
jQuery
Bootstrap
WordPress
SEO
Yoast SEO
Comments
No comments yet. Be the first to share your take.
Frequently asked
What does Immunyx Pharma do?
Immunyx Pharma is a drug development company focused on neutrophil modulation in disease. They are developing novel pharmacological approaches to safely and effectively treat deregulated neutrophil damage in large market diseases such as COPD, cancer, colitis, and arthritis.
When was Immunyx Pharma founded?
Immunyx Pharma was founded in 2017.
What industry does Immunyx Pharma operate in?
Immunyx Pharma operates in Life Sciences, Biopharmaceutical, Drug Development, Biotech, MedTech, HealthTech.
How many employees does Immunyx Pharma have?
Immunyx Pharma has approximately 6 people on record.